Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Bridgepoint Growth in conjunction with the entry of a partnership in DCHud Holding AB
Mandate

Vinge advises Bridgepoint Growth in conjunction with the entry of a partnership in DCHud Holding AB

November 10, 2020 Employment and Benefits Commercial Agreements M&A Corporate Crime & Compliance

Diagnostiskt Centrum Hud, the leading provider of medical dermatology services in Sweden, partnered with Bridgepoint Growth to further support the company’s expansion.

Today DCH operates six clinics across four Swedish cities and is the clear market leader in Sweden.

Vinge’s team primarily consisted of partner Daniel Rosvall together with associates Michaela Cronemyr, Elsie Nassar, Ellinor Wargenbrant and Olivia Belding (M&A) and Sara Strandberg (employment), Lisa Hörnqvist (commercial agreements) and Tove Lövgren Frisk (corporate, crime & compliance).

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

 Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025